Early pharmacological venous thromboembolism prophylaxis reduces lower limb deep vein thrombosis in surgical patients with severe hypertensive intracerebral hemorrhage: a retrospective cohort study

Frontiers in Neurology 2026 Open access

Read full text
Authors: ZhongXin Yang, Zongxi Li, Tianquan Zhao, Kai Feng Yu, L. M. Zhang, Xun Xia
DOI: 10.3389/fneur.2026.1800147
Cited by: 1
References: 31

Abstract

Objective: To investigate the efficacy and safety of early pharmacological prophylaxis for venous thromboembolism (VTE) on the incidence of lower extremity deep vein thrombosis (DVT) in patients undergoing surgery for severe hypertensive intracerebral hemorrhage (HICH). Methods: In this retrospective cohort study, 123 surgical patients with severe HICH admitted between September 2021 and February 2025 were included. Based on the initiation timing of VTE pharmacological prophylaxis (low-molecular-weight heparin calcium, LMWH), patients were categorized into an early group (prophylaxis initiated within 0.05). Conclusion: For surgical patients with severe HICH, early postoperative (

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Intracerebral and Subarachnoid Hemorrhage Research Atrial Fibrillation Management and Outcomes

Publication details

Journal / source
Frontiers in Neurology
Publisher
Frontiers Media SA
Volume
17
Pages
1800147–1800147
Publication date
10 April 2026
Language
EN